Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Fever, a hallmark of disease, is elicited by exogenous pyrogens, that is, cellular components, such as lipopolysaccharide (LPS), of infectious organisms, as well as by non-infectious inflammatory insults. Both stimulate the production of cytokines, such as interleukin (IL)-1beta, that act on the brain as endogenous pyrogens. Fever can be suppressed by aspirin-like anti-inflammatory drugs. As these drugs share the ability to inhibit prostaglandin biosynthesis, it is thought that a prostaglandin is important in fever generation. Prostaglandin E2 (PGE2) may be a neural mediator of fever, but this has been much debated. PGE2 acts by interacting with four subtypes of PGE receptor, the EP1, EP2, EP3 and EP4 receptors. Here we generate mice lacking each of these receptors by homologous recombination. Only mice lacking the EP3 receptor fail to show a febrile response to PGE2 and to either IL-1beta or LPS. Our results establish that PGE2 mediates fever generation in response to both exogenous and endogenous pyrogens by acting at the EP3 receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice lacking the PGE 2 receptor EP3 [112] or microsomal prostaglandin E synthase-1 enzyme [121,122] were shown to have impaired febrile responses.”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [121]
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Fever: Role of Pyrogens and Cryogens
Kluger, M. J. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.93 · Cited by 1,215
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108
Self-citationAltered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773 · cited 1×
“Mice lacking the EP 1 or EP 3 receptors were generated nearly as describe”
MethodSelf-citationFailure of Parturition in Mice Lacking the Prostaglandin F Receptor
Sugimoto, Y., Yamasaki, A., Segi, E., Tsuboi, K., Aze, Y., Nishimura, T., Oida, H., Yoshida, N., Tanaka, T., Katsuyama, M., et al. (1997) · Science · doi:10.1126/science.277.5326.681 · Cited by 608
Self-citationKiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y., & Narumiya, S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701367 · Cited by 510
Self-citationMeng, F., & Lowell, C. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1661 · Cited by 479
Flier, J. S., Underhill, L. H., Saper, C. B., & Breder, C. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302609 · Cited by 374
Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice
Zheng, H., Fletcher, D., Kozak, W., Jiang, M., Hofmann, K. J., Corn, C. A., Soszynski, D., Grabiec, C., Trumbauer, M. E., Shaw, A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90154-x · Cited by 365
The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth
Nguyen, M., Camenisch, T., Snouwaert, J. N., Hicks, E., Coffman, T. M., Anderson, P. A. W., Malouf, N. N., & Koller, B. H. (1997) · Nature · doi:10.1038/36342 · Cited by 363
Cited by
Items 301–400 of 682
Kim, S. O., Harris, S. M., & Duffy, D. M. (2014) · Endocrinology · doi:10.1210/en.2013-2096 · Cited by 37
“The present studies show that EP1 can also promote cumulus expansion in primate follicles, which contrasts with findings of normal fertility in mice lacking EP1 expression (12, 54).”
BackgroundResultFukuda, E. Y., Lad, S. P., Mikolon, D., Iacobelli-Martinez, M., & Li, E. (2005) · Infection and Immunity · doi:10.1128/iai.73.7.4017-4024.2005 · Cited by 37
“One of the major metabolites of cyclooxygenases is PGE2, which can induce inflammation, fever, and pain reaction through the interaction with its receptors (19, 38, 41, 42).”
BackgroundKrall, C. M., Yao, X., Hass, M. A., Feleder, C., & Steiner, A. A. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00158.2010 · Cited by 37
Gaseous Mediators in Temperature Regulation
Branco, L. G. S., Soriano, R. N., & Steiner, A. A. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130053 · Cited by 43
“PGE 2 is thought to interact with EP3 receptors (244,373) causing a decrease in the intra-cellular level of cyclic AMP in preoptic neurons (328, 334), triggering a thermoeffector response that increases T b .”
Engblom, D., Ek, M., Ericsson‐Dahlstrand, A., & Blomqvist, A. G. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1391 · Cited by 36
“In particular, knock-out experiments in mice indicate that EP3 receptors are of importance for the generation of fever (Ushikubi et al., 1998), although morphological findings contradicting this idea also exist (Oka et al., 2000).”
BackgroundAfferent pathways for autonomic and shivering thermoeffectors
Nakamura, K. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63912-7.00016-3 · Cited by 45
Molecular biology of histidine decarboxylase and prostaglandin receptors
Ichikawa, A., Sugimoto, Y., & Tanaka, S. (2010) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.86.848 · Cited by 36
Self-citationArai, K., Ohno, T., Saeki, T., Mizuguchi, S., Kamata, K., Hayashi, I., Saigenji, K., Murata, T., Narumiya, S., & Majima, M. (2003) · Gut · doi:10.1136/gut.52.9.1242 · Cited by 36
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi‐Nishida, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214459 · Cited by 42
Self-citationFever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E2
Kita, Y., Yoshida, K., Tokuoka, S. M., Hamano, F., Yamazaki, M., Sakimura, K., Kano, M., & Shimizu, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133663 · Cited by 36
“Among 4 known PGE2 receptor subtypes [6], EP3 receptors (EP3R, encoded by Ptger3) mediate fever, as global Ptger3-knockout [7] and conditional Ptger3-knockout in the medial preoptic nucleus of the hypothalamus [8] prevent fever responses in mice.”
BackgroundRosseau, S., Hocke, A. C., Mollenkopf, H., Schmeck, B., Suttorp, N., Kaufmann, S. H. E., & Zerrahn, J. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02514.x · Cited by 34
Iwahashi, H., Takeshita, A., & Hanazawa, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5403 · Cited by 40
Popp, L., Häußler, A., Olliges, A., Nüsing, R. M., Narumiya, S., Geißlinger, G., & Tegeder, I. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2008.09.001 · Cited by 35
“…prostaglandin D1 receptor (DP1 / ) (Qu et al., 2006), prostaglandin E receptor (EP1 / (Watanabe et al., 1999), EP2 / (Hizaki et al., 1999), EP3 / (Ushikubi et al., 1998) and EP4 / (Segi et al., 1998)) and cyclooxygenase 1 and 2 (COX1 / , COX2 / ) deficient mice and age and sex matched wild type…”
MethodInfluentialSelf-citationKozak, W., & Kozak, A. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01042.2002 · Cited by 31
“Nevertheless, genetically engineered mice have already proven to be a valuable model in demonstrating the role of cytokines (27), cyclooxygenases (30), PG receptors (59), and complement (31) in fever.”
BackgroundYamamoto, T., Anggadiredja, K., & Hiranita, T. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fmj04003x5 · Cited by 36
Non-inflammatory Physiology of “Inflammatory” Mediators – Unalamation, a New Paradigm
Maddipati, K. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580117 · Cited by 36
“PGE2 is an immune modulator as well as endogenous pyrogen and EP3 receptor activation is an established physiological event in fever induction, one of the classical symptoms of inflammation (8, 54, 55).”
BackgroundNavarro, V. P., Iyomasa, M. M., Leite‐Panissi, C. R. A., Almeida, M. C., & Branco, L. G. S. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0113-2 · Cited by 32
“By interacting with EP3 receptors [25, 43] and consequently decreasing the intracellular level of cyclic Pflugers Arch - Eur J Physiol (2006) 453:73–82”
BackgroundBarak, O., Weidenfeld, J., Goshen, I., Ben‐Hur, T., Taylor, A. N., & Yirmiya, R. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00025-9 · Cited by 32
Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype
Reinold, H., Ahmadi, S., Depner, U. B., Layh, B., Heindl, C., Hamza, M., Pahl, A. M., Brune, K., Narumiya, S., Müller, U., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523618 · Cited by 32
Self-citationSasaoka, R., Terai, H., Toyoda, H., Imai, Y., Sugama, R., & Takaoka, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.080 · Cited by 31
Arachidonic Acid Metabolites and the Kidney
Harris, R. C., Breyer, M. D., & BREYER, R. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10013-2 · Cited by 32
Cytokines and Inflammatory Response in the Fetus and Neonate
Srinivasan, L., Harris, M. C., & Kilpatrick, L. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-35214-7.00128-1 · Cited by 36
EP3 prostanoid receptor isoforms utilize distinct mechanisms to regulate ERK 1/2 activation
Israel, D. D., & Regan, J. W. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.01.021 · Cited by 31
Kotani, T., Kobata, A., Nakamura, E., Amagase, K., & Takeuchi, K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093195 · Cited by 31
“Mice lacking EP1, EP3, or IP receptors were generated as described previously (Sugimoto et al., 1992; Ushikubi et al., 1998).”
MethodAihara, E., Hayashi, M., Sasaki, Y., Kobata, A., & Takeuchi, K. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087619 · Cited by 31
Is Survival Possible Without Arachidonate Metabolites in the Brain During Systemic Infection?
Zhang, J., & Rivest, S. (2003) · Physiology · doi:10.1152/nips.01415.2002 · Cited by 31
Relation between complement and the febrile response of guinea pigs to systemic endotoxin
Li, S., SEHIC, E., Wang, Y., Ungar, A. L., & Blatteis, C. M. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.6.r1635 · Cited by 32
Expression of PGE2 EP3 receptor subtypes in the mouse preoptic region
Vasilache, A. M., Andersson, J., & Nilsberth, C. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.048 · Cited by 33
Takeuchi, K., Ogawa, Y., Kagawa, S., & Ukawa, H. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.16.s2.21.x · Cited by 31
Shoji, Y., Takahashi, M., Takasuka, N., Niho, N., Kitamura, T., Sato, H., Maruyama, T., Sugimoto, Y., Narumiya, S., Sügimura, T., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi193 · Cited by 31
“Animals Mice lacking EP 3 receptor gene were generated as reported previously (17) and were backcrossed to the C57BL/6Cr strain for 10 generations.”
MethodSelf-citationWaschbisch, A., Fiebich, B. L., Akundi, R. S., Schmitz, M. L., Hoozemans, J. J. M., Candelario‐Jalil, E., Virtainen, N., Veerhuis, R., Slawik, H. C., Yrjänheikki, J., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03599.x · Cited by 34
“Although neuronal EP3 receptors have been implied in the generation of fever (Ushikubi et al. 1998), the activation of the hypothalamo-pituitary axis (Matsuoka et al.”
BackgroundDoğan, M. D., Ataoğlu, H., & Akarsu, E. S. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00739-0 · Cited by 34
Mapping PTGERs to the Ovulatory Follicle: Regional Responses to the Ovulatory PGE2 Signal
Kim, S. O., & Duffy, D. M. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.116.140574 · Cited by 30
“Butaprost (agonist) Mouse Increased cumulus expansion [138] AH6809 (antagonist) Mouse Decreased cumulus expansion, decreased oocyte nuclear maturation [138] Butaprost (agonist) Mouse Decreased oocyte nuclear maturation [135] Butaprost (agonist) Monkey Increased follicular angiogenesis [68] Butaprost (agonist) Monkey I…”
BackgroundMethodMechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis
Kirkby, N. S., Raouf, J., Ahmetaj‐Shala, B., Liu, B., Mazi, S. I., Edin, M. L., Chambers, M. G., Korotkova, M., Wang, X., Wahli, W., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz290 · Cited by 30
Simm, B., Ott, D., Pollatzek, E., Murgott, J., Gerstberger, R., Rummel, C. D., & Roth, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.034 · Cited by 32
Temperature Regulation and the Pathogenesis of Fever
Sajadi, M. M., & Mackowiak, P. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00055-2 · Cited by 31
Kobrzycka, A. T., Napora, P., Pearson, B. L., Pierzchała, K., Szewczyk, R., & Wieczorek, M. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1544-y · Cited by 29
“that PGE2 is involved in behavioral changes during disease but most of all in thermoregulatory processes [68, 94, 95]—EP3 receptor is involved in fever inducing [96].”
BackgroundTanaka, Y. R., Furuyashiki, T., Momiyama, T., Namba, H., Mizoguchi, A., Mitsumori, T., Kayahara, T., Shichi, H., Kimura, K., Matsuoka, T., et al. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07021.x · Cited by 35
“Ptger1 ⁄ ) mice were generated, back-crossed more than 10 generations to C57BL ⁄ 6CrSlc mice and bred as described previously (Ushikubi et al., 1998; Matsuoka et al., 2003, 2005; Kitaoka et al., 2007).”
BackgroundMethodSelf-citationLeclerc, J. L., Lampert, A. S., Diller, M. A., & Doré, S. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12909 · Cited by 30
“Physiologically, EP3 has been shown to be important in fever induction, pain modulation, and regulation of the autonomic nervous system (Mantelli et al., 1991; Kumazawa et al., 1993; Minami et al., 1994; Yokotani et al., 1996; Ushikubi et al., 1998).”
BackgroundLebender, L. F., Prünte, L., Rumzhum, N. N., & Ammit, A. J. (2018) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2018.01.008 · Cited by 30
Choi, S., Choi, B., Suh, B., Chae, H.-D., Kim, J., Min‐Jung Shin, Kang, S., Negishi, M., & Kim, K. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00577.x · Cited by 29
“1998) and of body temperature (Ushikubi et al. 1998).”
Mouse models in colon cancer, inferences, and implications
Kucherlapati, M. H. (2023) · iScience · doi:10.1016/j.isci.2023.106958 · Cited by 33
Meloxicam affects the inflammatory responses of bovine mammary epithelial cells
Caldeira, M. O., Bruckmaier, R. M., & Wellnitz, O. (2019) · Journal of Dairy Science · doi:10.3168/jds.2019-16630 · Cited by 31
Inhibition of nitric oxide synthase accentuates endotoxin-induced sickness behavior in mice
Ribeiro, D. E., Maiolini, V. M., Soncini, R., Antunes‐Rodrigues, J., Elias, L. L. K., Vilela, F. C., & Giusti‐Paiva, A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.09.022 · Cited by 33
“, 2003), which activates a population of target neurons in the thermoregulatory center of the brain with specific PGE2 receptors (Ushikubi et al., 1998).”
Ohinata, K., Fujiwara, Y., Fukumoto, S., Iwai, M., Horiuchi, M., & Yoshikawa, M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.01.054 · Cited by 28
“For example, EP3 and EP4 receptors mediate the febrile response and wakefulness effect of PGE2, respectively [13,14].”
BackgroundInflammatory Cyclooxygenase Activity and PGE2 Signaling in Models of Alzheimer’s Disease
Johansson, J. U., Woodling, N. S., Shi, J., & Andreasson, K. I. (2015) · Current Immunology Reviews · doi:10.2174/1573395511666150707181414 · Cited by 31
“The EP3 receptor is a central component in the regulation of the febrile response [87, 88].”
Gao, W., Schmidtko, A., Wobst, I., Lu, R., Angioni, C., & Geißlinger, G. (2009) · PubMed · Cited by 28
Involvement of CRH in fever induced by a distinct pre-formed pyrogenic factor (PFPF)
Zampronio, A. R., Melo, M. C. C., Hopkins, S. J., & de Souza, G. E. P. (2000) · Inflammation Research · doi:10.1007/s000110050619 · Cited by 28
Regulation of Purinergic Signaling by Prostaglandin E2 in Murine Macrophages
Ito, M., & Matsuoka, I. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08087fp · Cited by 31
Kelley, L. P., & Kinsella, B. T. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705695 · Cited by 27
“…of these receptors display unique character- istic phenotypes including a reduction in carcinogen-induced colorectal cancer in EP1-deficient mice (Ushikubi et al., 1998; Watanabe et al., 1999; Sugimoto et al., 2000), loss of parturition affecting both ovulation and fertilization in…”
BackgroundOno, K., Akatsu, T., Kugai, N., Pilbeam, C. C., & Raisz, L. G. (2003) · Bone · doi:10.1016/s8756-3282(03)00264-3 · Cited by 28
“PGE2 has many physiological effects in many tissues through different receptor subtypes, for example EP2 and EP4 work for relaxation of smooth muscle and EP3 produces fever and mediates gastric protection [12,38].”
BackgroundDuffy, D. M., & VandeVoort, C. A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.048 · Cited by 28
“Ushikubi F, Segi E, Sugimoto Y, Murata T, Matsuoka T, Kobayashi T, et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3.”
BackgroundVasconcelos, R. M. C., Leite, F. C., Leite, J. A., Rodrigues‐Mascarenhas, S., Rodrigues, L. C., & Piuvezam, M. R. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.694891 · Cited by 31
“PGE2 participates in the inflammatory edema formation through EP3 receptors associated to G protein, which mediates the transcription of pro-inflammatory factors, stimulates nociception and is related to fever in inflammatory illnesses.((43,44)) The BS reduced paw edema triggered by PGE2.”
BackgroundPyrogenic signaling via vagal afferents: what stimulates their receptors?
Blatteis, C. M., & Li, S. (2000) · Autonomic Neuroscience · doi:10.1016/s1566-0702(00)00221-6 · Cited by 28
Saiga, A., Uozumi, N., Ono, T., Seno, K., Ishimoto, Y., Arita, H., Shimizu, T., & Hanasaki, K. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.10.001 · Cited by 26
A subsidiary fever center in the medullary raphé?
Tanaka, M., & McAllen, R. M. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00141.2005 · Cited by 32
Wang, W., Andersson, M., Lönnroth, C., Svanberg, E., & Lundholm, K. (2005) · International Journal of Cancer · doi:10.1002/ijc.20539 · Cited by 26
Central Mechanisms of Thermoregulation and Fever in Mammals
Nakamura, K. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4584-5_10 · Cited by 30
Hayashi, S., Sumi, Y., Ueno, N., Murase, A., & Takada, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.036 · Cited by 26
Role of EP2and EP4receptors in airway microvascular leak induced by prostaglandin E2
Jones, V. C., Birrell, M. A., Maher, S. A., Griffiths, M., Grace, M. S., O’Donnell, V. B., Clark, S., & Belvisi, M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13400 · Cited by 24
“The EP1 receptor agonist (ONO-D1-004), the EP2 receptor agonist (ONO-AE1-259), the EP3 receptor agonist (ONO-AE-248) and the EP4 receptor agonist (ONO-AE1-329) were gifts from Ono Pharmaceuticals (Osaka, Japan).”
BackgroundInfluentialHeeney, A., Rogers, A., Mohan, H. M., Dermott, F. M., Baird, A. W., & Winter, D. C. (2020) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2020.106499 · Cited by 29
Frölich, S., Olliges, A., Kern, N., Schreiber, Y., Narumiya, S., & Nüsing, R. M. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00418.2011 · Cited by 26
Self-citationCOX-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studies.
Marwali, M. R., & Mehta, J. L. (2006) · PubMed · Cited by 25
Role of leukemia inhibitor factor (LIF) in decidualisation of murine uterine stromal cells in vitro
Fouladi-Nashta, A. A., Andreu, C., Nijjar, N., Heath, J., & Kimber, S. J. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1810477 · Cited by 25
“The levels of PGs and prostacyclins (particularly PGE2 and PGI2) increase in implantation sites compared with the pre-implantation uterus or interimplantation site (Bany et al. 1998, Ushikubi et al. 1998, Bany & Kennedy 1999).”
BackgroundGallant, M., Belley, M. L., Carrière, M., Châteauneuf, A., Denis, D., Lachance, N., Lamontagne, S., Metters, K. M., Sawyer, N., Slipetz, D. M., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00794-7 · Cited by 25
Taketomi, Y., Higashi, T., Kano, K., Miki, Y., Mochizuki, C., Toyoshima, S., Okayama, Y., Nishito, Y., Nakae, S., Tanaka, S., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.06.012 · Cited by 27
Murakami, M., Takamiya, R., Miki, Y., Sugimoto, N., Nagasaki, Y., Suzuki-Yamamoto, T., & Taketomi, Y. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115176 · Cited by 28
Pascoe, M. C., Crewther, S. G., Carey, L. M., & Crewther, D. P. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.03.013 · Cited by 38
Inhibition of cytosolic phospholipase A2 alpha protects against focal ischemic brain damage in mice
Zhang, J., Barasch, N., Li, R.-C., & Sapirstein, A. (2012) · Brain Research · doi:10.1016/j.brainres.2012.06.031 · Cited by 24
“The generation of prostaglandin E2 through the COX-2 enzyme is an important step in the signaling cascade for fever in the mouse (Ushikubi et al., 1998).”
BackgroundLimeMap: a comprehensive map of lipid mediator metabolic pathways
Nishi, A., Ohbuchi, K., Kaifuchi, N., Shimobori, C., Kushida, H., Yamamoto, M., Kita, Y., Tokuoka, S. M., Yachie‐Kinoshita, A., Matsuoka, Y., et al. (2021) · npj Systems Biology and Applications · doi:10.1038/s41540-020-00163-5 · Cited by 25
Königsson, K., Odensvik, K., & Kindahl, H. (2002) · Zentralblatt für Veterinärmedizin Reihe A · doi:10.1046/j.1439-0442.2002.00461.x · Cited by 24
Fujino, T., Yuhki, K., Yamada, T., Hara, A., Takahata, O., Okada, Y., Xiao, C., Ma, H., Karibe, H., Iwashima, Y., et al. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704749 · Cited by 24
Self-citationInterleukin-6 Induces Prostaglandin E2 Synthesis in Mouse Astrocytes
Chikuma, T., Yoshimoto, T., Ohba, M., Sawada, M., Kato, T., Sakamoto, T., Hiyama, Y., & Hojo, H. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9187-6 · Cited by 26
“In the central nervous system (CNS), PGE2 is responsible for fever induction (Ushikubi et al. 1998) and participates in eliciting pain hypersensitivity (Samad et al.”
BackgroundNilsberth, C., Hamzic, N., Norell, M., & Blomqvist, A. G. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01888.x · Cited by 24
Minami, T., Matsumura, S., Mabuchi, T., Kobayashi, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S., & Ito, S. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00133-3 · Cited by 29
Self-citationSuzuki, C., Miyamoto, C., Furuyashiki, T., Narumiya, S., & Ohinata, K. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.06.004 · Cited by 23
“It was reported that EP3 receptor mediates the febrile response induced by bacterial endotoxin lipopolysaccharide (LPS), which mimics the condition of systemic sickness [3].”
BackgroundSelf-citationBorton, L., & Coleman, K. P. (2018) · ALTEX · doi:10.14573/altex.1709221 · Cited by 29
“…ISO 10993-11:2017, Annex G Pyrogenic substances Reference providing evidence of pyrogenicity Cytokines: e.g., IL-1, IL-6, TNFα, INF-γ Dinarello, 2004; Ushikubi et al., 1998 Prostaglandins Dinarello, 2004; Ushikubi et al., 1998 Neurotransmitters Dinarello, 2004; Laburn et al., 1974 Inducers:…”
InfluentialKawada, N., Moriyama, T., Kitamura, H., Yamamoto, R., Furumatsu, Y., Matsui, I., Takabatake, Y., Nagasawa, Y., Imai, E., Wilcox, C., et al. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-011-0492-3 · Cited by 27
Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor
Imanishi, J., Morita, Y., Yoshimi, E., Kuroda, K., Masunaga, T., Yamagami, K., Kuno, M., Hamachi, E., Aoki, S., Takahashi, F., et al. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.035 · Cited by 23
“For example, fever was induced by direct injection of PGE2 into the third ventricle of the brain [37], and mice lacking the PGE receptor subtype EP3 showed impaired febrile response [38].”
BackgroundGale, G. A., Kirtikara, K., Pittayakhajonwut, P., Sivichai, S., Thebtaranonth, Y., Thongpanchang, C., & Vichai, V. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.016 · Cited by 33
Axelsson, H., Lönnroth, C., Wang, W., Svanberg, E., & Lundholm, K. (2006) · Angiogenesis · doi:10.1007/s10456-005-9023-8 · Cited by 23
“Both EP1 and EP3 targeted structures were Neo-inserted form and the expected genomic defects were checked [16].”
BackgroundSaiga, A., Morioka, Y., Ono, T., Nakano, K., Ishimoto, Y., Arita, H., & Hanasaki, K. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00167-0 · Cited by 23
Mota, C. M. D., & Madden, C. J. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.04.008 · Cited by 26
Prostaglandin E2 Attenuates Preoptic Expression of GABAA Receptors via EP3 Receptors
Tsuchiya, H., Oka, T., Nakamura, K., Ichikawa, A., Saper, C. B., & Sugimoto, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801359200 · Cited by 22
Self-citationIdentification of novel mPGES-1 inhibitors through screening of a chemical library
Park, S., Han, S., Ahsan, H. M., Lee, K., Lee, J. Y., Shin, J., Lee, K., Kang, N.-S., & Yu, Y. G. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.10.085 · Cited by 22
Role of an excitatory preoptic-raphé pathway in febrile vasoconstriction of the rat's tail
Tanaka, M., McKinley, M. J., & McAllen, R. M. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00401.2013 · Cited by 24
“How does PGE2 activate tail SNA? The EP3 receptor is thought to be the critical receptor responding to PGE2 to mediate the febrile response (9, 50).”
Osaka, T. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0443-8 · Cited by 22
“Among these, the EP3 receptor is present densely in the peri-OVLT region [14] and mediates PGE2-induced fever [35], although the EP1 and EP4 receptor may also be partly involved in fever [18, 19].”
BackgroundDiscovery of novel N-acylsulfonamide analogs as potent and selective EP3 receptor antagonists
Asada, M., Obitsu, T., Kinoshita, A., Nakai, Y., Nagase, T., Sugimoto, I., Tanaka, M., Takizawa, H., Yoshikawa, K., Sato, K., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.034 · Cited by 22
Becker, J. H., & Wu, S. (2010) · Journal of the American Podiatric Medical Association · doi:10.7547/1000281 · Cited by 23
Saper, C. B. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374236-0.10016-1 · Cited by 27
Ibrahim, N., Shibuya, I., Kabashima, Sutarmo, Ueta, & Yamashita (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00404.x · Cited by 22
CCK2receptor nullification attenuates lipopolysaccharide-induced sickness behavior
Weiland, T. J., Voudouris, N. J., & Kent, S. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00156.2006 · Cited by 26
Takeuchi, K., Aihara, E., Sasaki, Y., Nomura, Y., & Ise, F. (2006) · PubMed · Cited by 22
Diverse effects of prostaglandin E2 on vascular contractility
Kida, T., Sawada, K. B., Kobayashi, K., Hori, M., Ozaki, H., & Murata, T. (2013) · Heart and Vessels · doi:10.1007/s00380-013-0374-6 · Cited by 21
“PGE2 is involved in major inflammatory events such as fever generation [2], wound healing [3], and vascular tone regulation [1, 4].”
BackgroundSelf-citationBody thermal responses and the vagus nerve
Chang, R. B. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.013 · Cited by 26
“For example, a variety of cytokine receptors that may be involved in febrile responses were identified in vagal sensory neurons, including CXCR2 (a receptor for interleukin 8 (IL8) and chemokine (C-X-C motif) ligand 1 (CXCL1/MGSA)) [108], IL1R (receptor for interleukin 1 (IL1)) [26, 93, 100], TLR4 (Toll-like receptor…”
BackgroundRoth, A., Kyzar, E. J., Cachat, J., Stewart, A., Green, J. B. A., Gaikwad, S., O’Leary, T. P., Tabakoff, B., Brown, R. E., & Kalueff, A. V. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.015 · Cited by 22
“For example, the mammalian phenotype for prostaglandin E receptor 3 (Ptger3) mutation includes an abnormal body temperature and impaired pain threshold (Ushikubi et al., 1998), which may produce variation in thermoregulation and subsequently affect baseline grooming behavior.”
Bone formation and tooth movement are synergistically enhanced by administration of EP4 agonist
Chung, C. J., Baik, H.-S., & Soma, K. (2007) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1016/j.ajodo.2007.02.049 · Cited by 21
Food Intake Regulation by Central Complement System
Ohinata, K., & Yoshikawa, M. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_3 · Cited by 21
The roles of prostanoids in infection and sickness behaviors
Matsuoka, T., & Narumiya, S. (2008) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-008-0622-3 · Cited by 21
Self-citationCentral prostaglandins in food intake regulation
Ohinata, K., & Yoshikawa, M. (2008) · Nutrition · doi:10.1016/j.nut.2008.06.006 · Cited by 22
“[7] Ushikubi F, Segi E, Sugimoto Y, Murata T, Matsuoka T, Kobayashi T, et al.”
Background
Metadata
- Authors
- Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., Tanaka, T., Yoshida, N., & Narumiya, S.
- Affiliations
- Kyoto University (JP)
- Osaka Women's and Children's Hospital (JP)
- Corresponding author
- Narumiya, Shuh
- Venue
- Nature
- Published
- 1998-09
- Volume
- 395
- Issue
- 6699
- Pages
- 281-284
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1647648618
- Cited by
- 677
- References
- 30
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 15 · 2020: 15 · 2019: 11 · 2018: 18 · 2017: 14 · 2016: 18 · 2015: 24 · 2014: 14 · 2013: 12 · 2012: 22
- FWCI
- 32.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Thermal Regulation in Medicine
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- fever, prostaglandin E2, EP3 receptor, prostaglandin E receptors, IL-1β, lipopolysaccharide, exogenous pyrogens, endogenous pyrogen, receptor knockout mice, prostaglandin synthesis
- MeSH terms
- Animals, Crosses, Genetic, Fever, Interleukin-1, Lipopolysaccharides, Mice, Inbred C57BL, Pyrogens, Dinoprostone, Receptors, Prostaglandin E, Gene Targeting, Mice, Receptors, Prostaglandin E, EP3 Subtype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.